Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Persistent Pain in Pharmacologically or Surgical Treated Osteoarthritis: the Role of the Mu-Lympho Marker As a Candidate Innovative Diagnostic Tool

NCT06637709 is registered in ClinicalTrials.gov with IRCCS San Raffaele Roma as lead sponsor.

NCT NCT06637709
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06637709 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Persistent Pain in Pharmacologically or Surgical Treated Osteoarthritis: the Role of the Mu-Lympho Marker As a Candidate Innovative Diagnostic Tool
Lead sponsor
IRCCS San Raffaele Roma
Phase
Observational
Overall status
Recruiting
Start date
November 7, 2023
Completion date
April 28, 2026
Enrollment
192 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic pain, osteo arthritis knee